Abstract. The hemodynamic consequences of the hypoxic inhibition of angiotensin-converting enzyme activity were studied in chronically instrumented unanesthetized sheep (n = 8) breathing a hypoxic gas mixture for 60 min (Pao2 = 31 mm Hg) followed by reoxygenation with room air. Changes in cardiac output, vascular pressures, blood flow distribution, arterial pH, Paco2, Pao2, and arterial levels of plasma renin activity, angiotensin II, bradykinin, and catecholamines were measured at selected time points. Seven additional sheep underwent the same protocol but received saralasin, an angiotensin II receptor blocker beginning at 55 min of hypoxia and extending into the reoxygenation period. During hypoxia, both groups developed identical hemodynamic patterns including a rise in cardiac output (25%), blood pressure (15%), and preferential blood flow distribution to the heart, brain, adrenals, diaphragm, and skeletal muscle, as well as a decrease in the fraction of cardiac output to the kidneys and most ofthe gut. This was associated with a decrease in angiotensin II concentrations (from 35 to 17 pg/ml) in spite of a doubling in plasma renin activity and catecholamines. Bradykinin levels did not change. Upon reoxygenation, bolus production of angiotensin II (from 17 to 1,819 pg/ml) occurred in spite of a constant level of plasma renin activity. Concurrently, different he-
Introduction
The lung is responsible for important metabolic functions involving the activation or degradation of many classes of circulating vasoactive substances which include circulating or tissue factors that mediate changes in blood pressure, vascular resistance, cardiac output, blood volume, or the transvascular exchange of fluid and protein (1) . The biochemical processes that underlie the pulmonary handling of these substances are welldescribed, and the endothelial cell is recognized as the cell type that is principally responsible for these functions. Nonetheless, there remains as yet little evidence that, by regulating the circulating levels of highly vasoactive compounds, the lung participates in physiologic processes or whether interference with this lung function contributes to the genesis of disease.
One well-recognized function of the pulmonary endothelial cell is the activation of angiotensin I (Al)' to angiotensin II (AII) and the degradation of bradykinin by angiotensin-con-verting enzyme (ACE). Previous work from our laboratory has demonstrated that ACE activity is rapidly and reversibly inhibited by hypoxia in vivo (2, 3) and in endothelial cell culture in vitro (4) . In previous publications, we suggested that this phenomenon contributed to: (a) abnormal circulatory responses to stress in a canine model of pulmonary emphysema (5), (b) the physiologic adaptations of the circulation at the time of birth (6) , and (c) the edema-producing effect of bradykinin in the hypoxic pulmonary vascular bed (7, 8) .
The present study was designed to determine the hemodynamic consequences of the modulation of ACE activity by oxygen tension during acute hypoxia as well as during abrupt reoxygenation. Since we observed a fall in arterial All with the onset of hypoxia in preliminary studies in anesthetized dogs (3), we hypothesized that, by virtue of this effect on All, the acute hypoxic inhibition of ACE would contribute to a physiologic redistribution of blood flow and prevent an unfavorable increase in systemic vasomotor tone and cardiac work. Furthermore, we hypothesized that reoxygenation would lead to rapid restoration of ACE activity and the sudden delivery of All to the systemic circulation with consequent effects on blood pressure and blood flow distribution.
To examine these questions, we used unanesthetized, chronically instrumented sheep preparations to study the time course of simultaneous changes in plasma renin activity (PRA), All, and bradykinin during hypoxia and reoxygenation, concurrent with changes in cardiac output, vascular resistance, and the distribution of blood flow to vital organs. In addition, levels of circulating catecholamines were measured as indices of sympathetic nervous system activity and adrenal medullary output for two reasons: (a) the sympathetic nervous system is known to play an important role in the circulatory response to hypoxia (9) and (b) there are important synergistic actions between the sympathetic and renin-angiotensin systems (10) .
Methods
Animal preparation and experimental protocol. 15 chronically instrumented, unanesthetized sheep weighing 18-30 kg were used in these experiments. After induction (pentothal, 300 mg i.v.) and general anesthesia (1-2% halothane), a thoractomy was performed through the left third intercostal space. Polyvinyl catheters (i.d. = 1 mm) were placed in the right and left atria and main pulmonary artery. The abdominal aorta was catetherized via the right femoral artery or its superficial branch, the saphenous artery. A short wide bore catheter was placed in the left external jugular vein. The latter served as the insertion site for a cardiac output thermodilution catheter on the day prior to experimentation. Its position was verified by a pulmonary wedge pressure tracing.
The sheep were allowed to recover from surgery for a minimum of 7 d. On the first postoperative day, 150 ml of blood was withdrawn from the sheep and refrigerated in a sterile citrate phosphate-dextrose blood bank bag. This blood was rewarmed and used during the experiment to replace blood withdrawn from microsphere reference flow. All sheep were afebrile and had base-line hemodynamic and blood gas data consistent with previously published work (7) . Animals were studied standing in their cage. A light plastic hood with venting tubes was placed over each animal's head. Gas mixtures with known concentrations of 02 and N2 were delivered to the animals at gas flows > 10 liters/min to prevent rebreathing. Base-line hemodynamic and biochemical data were determined over an initial 30-min interval of room air breathing (20% 02, 80% N2). The animals were then abruptly switched to the hypoxic gas mixture (10% 02, 90% N2) for a 60-min interval. This gas mixture was chosen to achieve a Pao2 between 30-40 mm Hg; in this range, angiotensin-converting enzyme activity is markedly inhibited (2) . Because inhibition of enzyme activity is rapidly reversible, we then abruptly switched the gas back to room air, and continued observations for 60 min after reoxygenation.
Vascular pressures were continuously recorded on a polygraph recorder (Beckman Instruments, Inc., Fullerton, CA) by using pressure transducers (P23b, Gould-Statham Instrument Inc., Oxnard, CA) with zero reference at the mid-chest level. Cardiac output, heart rate, arterial blood gases and acid-base status, and hematocrit and vasoactive mediators were measured during base-line room air breathing (15 and 25 min after starting observations), hypoxic gas breathing (5, 10, 30 , and 55 min after onset), and reoxygenation with room air (5, 10, 15, 30 , and 60 min after onset). Cardiac output was determined in triplicate by thermodilution using a computer (Kimray Medical Associates, Inc., Oklahoma City, OK). Systemic vascular resistance was calculated by using the difference of the mean systemic arterial and mean right atrial pressure divided by the mean cardiac output. Heart rate was determined from a 10-s aortic pressure tracing. An index of myocardial work and oxygen consumption, the heart rate-systolic pressure product (1 1), was calculated at each sampling point. Blood samples from the aortic catheter were drawn to measure PRA, AII, catecholamines, bradykinin, Pao2, Paco2, and arterial pH (pHa) (IL 513 pH/blood gas analyzer, Instrumentation Laboratory, Inc., Lexington, MA). A total of 4.5 ml ofblood was required at each time point.
Eight sheep were used to describe the time course of change in systemic hemodynamics and circulating vasoactive mediators during acute hypoxia followed by abrupt reoxygenation. In seven other sheep, we used the same experimental protocol except for the infusion of l-sarcosine, 8-ala, All (AII receptor blocker, saralasin) (CalbiochemBehring Corp., San Diego, CA) at 20 ag/kg per min beginning 5 min before and lasting for 15 min after the onset of reoxygenation. Saralasin was delivered in 0.1% lysozyme and normal saline at 1 ml/min via the right atrial catheter. In preliminary experiments, we found no effect of 0.1% lysozyme at 1 ml/min on resting blood pressure and heart rate, and no effect of this saralasin infusion on resting heart rate and blood pressure. However, within S min, this saralasin infusion could completely prevent a 20 mm Hg rise in mean systemic arterial blood pressure after the injection of 1 jig of AI into the right atrium.
Radiolabeled microsphere technique. The distribution of systemic blood flow was determined at five selected time points based on previous work which indicated critical time points for changes in circulating vasoactive mediators during hypoxia (3). Five separate injections of differently labeled microspheres were made during base-line room air breathing, at 5 and 55 min after the onset of hypoxia, and at 5 and 15 min after reoxygenation. Each microsphere injection was made immediately after sampling for blood gases and vasoactive mediators at corresponding time points.
The microsphere methods used in our experiments are similar to those published in extensive reviews ofthis method (12, 13 Hemodynamic data on animals receiving saralasin at 5 min before reoxygenation were collected in a second set of experiments. To rule out the effect of elapsed time between the groups of experiments as a factor in the interpretation of results, mean base lines were compared by using a t test between control and saralasin groups. Since no significant differences were found in base-line data between control and saralasin groups, the hypoxia data were analyzed by using a two factor repeated measures analysis of variance on the changes from mean base-line values. The two factors were group (control and saralasin) and time of measurement. No significant differences in any variable were obtained between control and saralasin data during hypoxia, so it was justifiable to compare the reoxygenation data. These were analyzed by using a two factor repeated measures analysis of variance with group and time as factors.
In all analyses of variance, statistical tests for interaction between factors were performed prior to tests on the factors themselves. In the absence of interaction, main effects were tested directly, while in the presence of interaction, means were tested time by time using the appropriate mean square. If it was necessary to pool error mean squares, the appropriate degrees of freedom for the resulting error mean square were determined by using a Sattertwaithe approximation. The Bonferroni method was used to give an overall level of statistical significance of P < 0.05; that is, if 10 statistical tests were possible in a given analysis, a test was considered significant at the P < 0.005 level (16) .
The changes from base line for the chemical mediators were not normally distributed (skewed with a long tail to the right) and hence were transformed with a logarithmic transformation.
Results
Arterial blood gases and acid-base status were the same in control and saralasin groups during the base-line, hypoxia, and reoxygenation periods. Breathing a hypoxic gas mixture of 10% 02 and 90% N2 resulted in moderately severe hypoxia with respiratory alkalosis (Table I) . Over the 1-h period of hypoxia, the mean values for pHa, PacO2, and Pao2 were 7.55, 29 mm Hg, and 31 mm Hg, respectively. The base deficit did not exceed 5 meq/liter in any animal. Upon reoxygenation, the arterial blood gases and acid-base status returned to base line within 5 min.
Vasoactive mediator response. The time course of change in arterial catecholamines, PRA, and All levels in response to acute hypoxia and reoxygenation are shown in Fig. 1 . Total arterial catecholamines (epinephrine plus norepinephrine plus dopamine) rose to values significantly above base line during the entire hypoxic period. The peak was at 10 min with a mean level of 898 pg/ml representing a 143% increase above base line; thereafter, between 30 when data was pooled from both the control and saralasin groups (P < 0.01).
Blood flow distribution data during base-line, hypoxia, and reoxygenation periods are shown in Table IV . Tissues that received a significant (P < 0.05) increase in absolute blood flow during the entire hour ofhypoxia include gray and white matter, myocardium, adrenal gland, diaphragm, and skeletal muscle. Only the outer renal cortex and spleen received a significant decrease in absolute blood flow. In general, there were no significant changes in absolute stomach, intestinal, and hepatic (arterial) blood flow during hypoxia. Since preliminary experiments ruled out nonentrapment, lung and liver values represent blood flow from the bronchial and hepatic arterial circulation, respectively.
The percent change in the fraction ofcardiac output is listed in Table IV Hemodynamic response to reoxygenation. Fig. 3 illustrates the hemodynamic data obtained during the hypoxic period (at 55 and 60 min) as well as the data obtained in the reoxygenation period for both control and saralasin groups. There was no difference between these groups in cardiac output, heart rate, mean systemic arterial pressure, and systemic vascular resistance during hypoxia, and the saralasin infusion (which was started at 55 min of hypoxia) had no effect on these hemodynamic parameters for the remaining 5 min of the hypoxic period. However, 5 min after reoxygenation, two different hemodynamic patterns developed between the control and saralasin groups. Cardiac output dropped immediately to base-line values in both groups. In the control group, blood pressure rose above the values at the end of hypoxia and thus above base line as well. In the saralasin group, blood pressure returned to base line upon reoxygenation. The rise in blood pressure observed in the control group upon reoxygenation was highly significant for at least 60 min after restoring room air breathing. Similarly, there was a significant difference in the pattern of response for systemic vascular resistance for the two groups; the large increase above base line in the control group was completely prevented by saralasin. Heart rate dropped to the same levels for both groups upon reoxygenation, though there was a trend towards slower heart rates in the saralasin-treated group.
We found no difference in the cardiac output and distribution of blood flow between control and saralasin groups when these measurements were made at 5 and 15 min after reoxygenation. A trend towards lower muscle blood flow was observed in the control group compared with the saralasin group at 5 min after reoxygenation, but this did not reach statistical significance (P = 0.1). Myocardial blood flow, which was equally elevated in both groups before saralasin and reoxygenation, returned to base-line values in both groups by 5 min of reoxygenation. However, the heart rate-systolic pressure product for the control group remained significantly higher than the product for the saralasin group which returned to base line (Fig. 4) .
Discussion
Hypoxia is often present in many cardiopulmonary diseases and is known to result in severe inhibition of an important Figure 3 . Hemodynamic measurements after 1 h of hypoxia (only the values after 55 min of hypoxia are shown) followed by reoxygenation in control and saralasin groups. Saralasin was administered to sheep immediately after measurements at 55 min of hypoxia (Pao2 = 31 mm Hg); during the remaining 5 min of hypoxia, there was no change in blood pressure in either group. However, immediately, upon reoxygenation, saralasin blocked the rise in blood pressure and systemic vascular resistance that was observed in the control group. *, P < 0.05; L, liter. metabolic function ofthe lung, ACE activity (2, 4). To examine the hemodynamic consequences of the hypoxic modulation of ACE activity, we studied chronically instrumented, unanesthetized sheep breathing a hypoxic gas mixture followed by abrupt reoxygenation with room air. During 1 h of hypoxia, mean arterial blood pressure rose initially and then returned to base line, and cardiac output rose and remained elevated. There was a redistribution of blood flow toward the brain, heart, adrenals, diaphragm, and skeletal muscle, and away from the splanchnic circulation. The total hemodynamic response agrees closely with work by other investigators using chronically instrumented, unanesthetized sheep (17). Simultaneous measurements of vasoactive mediators during these hemodynamic changes demonstrated that the arterial concentration of All dropped despite Hemodynamic and vasoactive mediator response to acute hypoxia. With the onset of acute hypoxia and consequent fall in blood oxygen content, one task ofthe circulation is to increase cardiac output so that systemic oxygen delivery is maintained. Concurrently, a greater fraction of cardiac output is directed to organs vital to survival. The present study indicates that one mechanism for achieving an increase in cardiac output during hypoxia is by increasing skeletal muscle blood flow which at rest receives 20-25% of the cardiac output. Muscle blood flow (excluding muscle involved in breathing) increased over twofold during hypoxia without any apparent increase in muscle work because in all cases the sheep stood or laid quietly and unrestrained. We believe that this supports the concept of Caldini et al. (19) , who suggested that skeletal muscle serves as a fast time constant bed (through which blood moves very rapidly), having the effect of accelerating venous return to the heart. Therefore, an increase in flow out of the heart (cardiac output) is permitted because blood flow back to the heart (venous return) is accelerated. In some previously reported work, muscle flow did not increase with hypoxia (20) but this may have been related to acute surgery and anesthesia. Recent work in chronically instrumented, unanesthetized animals (17, 21) supports the finding that skeletal muscle blood flow increases during hypoxic stress.
In concert with the selective increases in organ blood flow to vital organs and muscle, blood flow is distributed away from the gastrointestinal tract and kidneys, presumably slow time constant beds (19) . The increase in splanchnic vascular resistance will help maintain blood pressure and contribute to the augmented blood flow to other organs. Blood flow distribution varies over time. For example, at 5 min after the onset ofhypoxia, the fraction of blood flow going to the muscle and away from the stomach and intestines was greater than the respective frac- Comparison of coronary blood flow and heart rate-systolic pressure product after I h of hypoxia followed by reoxygenation in control and saralasin groups. Saralasin was administered immediately after measurements made at 55 min of hypoxia (Pao2 = 31 mm Hg). Upon reoxygenation, coronary blood flow returned to 50 base line in both groups. However, the index of oxygen consumption was significantly greater than base line in the control group upon reoxygenation, a response which was blocked by saralasin. *, P < 0.05.
tion of blood going to these tissues at 55 min of hypoxia. It would appear from these patterns and the catecholamine data that, at the onset of acute hypoxia, a sympathetic reflex mechanism overrides local vascular dilatation in the gut, but later a less striking effect is seen. Indeed, the circulatory response to hypoxia is complex and although total calculated systemic vascular resistance tends to drop by 1 h of hypoxic gas breathing, some vascular beds appear to have a marked increase in vasomotor tone reflected by an increase in systemic arterial closing pressure (22) . The role that circulating vasoactive mediators play in the hemodynamic adaptations to hypoxia are poorly understood. In the present experiments, we found that hypoxia increases PRA, as has also been shown by others (23) . The mechanism for the rise in PRA during hypoxia is not completely understood but is probably due to a catecholamine-mediated decrease in renal vascular threshold pressure for renin release (24) . Measurements of circulating catecholamines in the present study revealed an initial 162% increase over base line with 96% increase at the end of I h of hypoxia. Both norepinephrine and epinephrine rose to levels which would cause modest effects on blood pressure and cardiac output (25) . The norepinephrine levels, in part, represent washout from sympathetic nerve terminals and reflect increased sympathetic activity (26) .
While PRA increased during hypoxia, All levels remained low or dropped in the present study, confirming past work (3) . This can be explained by the hypoxic inhibition of ACE activity to a very low level. At a Pao2 of 35 mm Hg, measured converting enzyme activity was 30% of activity seen during normoxia using an Al pressor technique (27) and nearly 0% of normoxic activity using bradykinin clearance across the lung as a measure of ACE activity (2) . In the present study, bradykinin levels remained below the level of assay sensitivity, confirming past work that hypoxia is not associated with elevated circulating levels of bradykinin unless the kallikrein-kinin system is activated (2 With the onset ofreoxygenation, there was bolus production ofAll. All levels peaked at 5 min after the onset ofreoxygenation with a mean value of 1,819 pg/ml and returned to normal values by 1 h. These high levels ofAll occurred without a simultaneous change in PRA or circulating catecholamines. This can be explained by the sudden restoration of ACE activity upon reoxygenation and conversion of AI substrate which increased in concentration during marked hypoxic inhibition of enzyme activity. At the end of the reoxygenation period, All levels dropped to the base-line range in spite of a persistent elevation in PRA. Possible explanations for this observation include transient angiotensinogen depletion causing a decrease in Al production in spite of continued renin release or an increase degradation rate of All, after bolus production of All.
Since the publication of our several studies demonstrating this inhibition of converting enzyme activity by hypoxia (2, 4, 7, 8) , controversy has arisen as to both the extent and mechanism of this phenomenon. Szidon et al. (32) , administering bolus injections of trace doses of Al to anesthetized dogs, found a 20% decrease in conversion when the dogs were made hypoxic, which was attributed to a faster pulmonary transit time. However, when pressor doses of Al were administered, conversion fell to 30%, even lower than in our published studies of angiotensin conversion in hypoxia. Catravas and Gillis (33) found little effect ofhypoxia on conversion ofa synthetic ACE substrate, benzoyl-phe-ala-pro (BPAP). However, Gillis et al. (34) found a reduction of BPAP conversion in newborn lambs made hypoxic. The latter studies also revealed no effect of changes in transit time on conversion. Also, we recently confirmed our earlier observations on the inhibition of converting enzyme activity by hypoxia in endothelial cells in tissue culture, using BPAP as substrate (35) . Using four different doses of BPAP, we calculated an eightfold decline in maximum velocity (Vma,) for ACE in hypoxic cells, with essentially no change in Michaelis constant (Kn). We should emphasize that whatever the mechanism, extensive studies reveal that the handling of both ACE substrates, Al and bradykinin, is substantially altered by hypoxia, and the studies described in this manuscript demonstrate that hypoxia dissociates PRA from All formation and this altered peptide metabolism has important implications for cardiovascular physiology.
Effect of saralasin on the hemodynamic changes during reoxygenation. To assess the hemodynamic role of All upon reoxygenation, we studied a separate group ofanimals receiving saralasin, the specific All receptor blocker. Upon reoxygenation, the increase in systemic vascular resistance and blood pressure above base-line values was blocked. Cardiac output returned to base line in both control and saralasin groups. Coronary blood flow returned to base-line values in both control and saralasin groups within 5 min after reoxygenation. To determine if myocardial oxygen delivery met demand upon reoxygenation, we used the heart rate-systolic pressure product as an index of myocardial work. This index of work correlates well with oxygen consumption in the presence of elevated circulating catecholamines (1 1). Upon reoxygenation, cardiac work in the control group remained appreciably elevated above the level observed in the saralasin group and base line. This was explained by the AII-mediated rise in blood pressure upon reoxygenation. In addition, this hemodynamic effect of All may have been enhanced by the synergistic action of sympathetic nerve activity and circulating catecholamines (10), which were still elevated at the time of reoxygenation. Cardiac work was also elevated in the control group because heart rate remained elevated during reoxygenation. This may be explained by an All-mediated interference with vagal tone (36) . We conclude that, in the control group, All resulted in low coronary blood flow relative to cardiac work. When the All receptor was blocked by saralasin, the match between coronary blood flow and cardiac work was restored and cardiac work was reduced.
Sudden reoxygenation may have pathophysiologic circulatory effects, which have not been previously recognized, specifically in the coronary circulation. Gavras et al. (37) has shown that high levels of All similar to that seen in our experiment can cause myocardial ischemia and necrosis. This may have particular significance when a patient with severe coronary artery disease or infarction is being resuscitated or when the pulmonary circulation and its metabolic activities are suddenly restored after lung bypass. The present studies suggest that either an All receptor blocker or converting enzyme inhibitor may be useful in these situations. Future studies which directly examine myocardial oxygen delivery with and without a proximal critical coronary stenosis may delineate whether an All-mediated pathophysiologic circulatory pattern is indeed created upon reoxygenation.
The present experiments raise speculations for several problems pertaining to the care of critically ill patients. With the combination of hypoxia and acute hypovolemia, e.g., hemorrhage, PRA would likely be greatly elevated, but efficiency of pulmonary conversion of Al impaired. We speculate that abrupt reoxygenation may lead to an exaggerated All-mediated impairment in coronary and splanchnic blood flow (38) . Indeed, this clinical situation is not infrequently followed by such pathologic entities as ischemic cardiomyopathy and necrotizing enterocolitis. Since the vasoconstrictive effects of high concentrations of All are in part antagonized by angiotensin-stimulated release of dilator prostaglandins (39) , patients in these settings treated with cyclooxygenase inhibitors (aspirin, indomethacin) would likely be at higher risk for regional ischemic effects of bolus All formation. We speculate similarly that the hypoxic, prematurely born infant known to have impaired cerebral blood flow autoregulation after asphyxia (40) may be at enhanced risk for intraventricular hemorrhage if acute All-mediated hypertension accompanies resuscitation.
